Reclast Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Conditions:   Osteoporosis;   Osteoporosis, Postmenopausal;   Osteopenia;   Bone Loss Intervention:   Drug: Zoledronic acid Sponsor:   University of Calgary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)
Condition:   Osteoporosis Interventions:   Drug: Zoledronic acid, once;   Drug: Zoledronic acid, twice Sponsor:   Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2022 Category: Research Source Type: clinical trials